PL1848691T3 - Sposób otrzymywania pochodnych indolu - Google Patents

Sposób otrzymywania pochodnych indolu

Info

Publication number
PL1848691T3
PL1848691T3 PL06780510T PL06780510T PL1848691T3 PL 1848691 T3 PL1848691 T3 PL 1848691T3 PL 06780510 T PL06780510 T PL 06780510T PL 06780510 T PL06780510 T PL 06780510T PL 1848691 T3 PL1848691 T3 PL 1848691T3
Authority
PL
Poland
Prior art keywords
formula
group selected
preparation
atom
methylbenzylsulfonyloxy
Prior art date
Application number
PL06780510T
Other languages
English (en)
Inventor
Rohit Ravikant Soni
Hitarth Harshendu Acharya
Hetal Rameshchandra Shah
Trushar Rajnikant Shah
Buchi Reguri Reddy
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of PL1848691T3 publication Critical patent/PL1848691T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06780510T 2005-02-15 2006-02-15 Sposób otrzymywania pochodnych indolu PL1848691T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN77MU2005 2005-02-15
EP06780510A EP1848691B1 (en) 2005-02-15 2006-02-15 Process for the preparation of indolone derivative
PCT/IN2006/000052 WO2006123356A1 (en) 2005-02-15 2006-02-15 Process for the preparation of indolone derivative

Publications (1)

Publication Number Publication Date
PL1848691T3 true PL1848691T3 (pl) 2010-05-31

Family

ID=37027535

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06780510T PL1848691T3 (pl) 2005-02-15 2006-02-15 Sposób otrzymywania pochodnych indolu

Country Status (13)

Country Link
US (1) US7619095B2 (pl)
EP (1) EP1848691B1 (pl)
JP (1) JP2008530201A (pl)
KR (1) KR20070112196A (pl)
AT (1) ATE448201T1 (pl)
AU (1) AU2006248578A1 (pl)
BR (1) BRPI0608244A2 (pl)
CA (1) CA2597791A1 (pl)
DE (1) DE602006010329D1 (pl)
ES (1) ES2336486T3 (pl)
PL (1) PL1848691T3 (pl)
WO (1) WO2006123356A1 (pl)
ZA (1) ZA200707888B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008084499A1 (en) * 2007-01-10 2008-07-17 Ind-Swift Laboratories Limited An industrial process for the preparation of pure ropinirole
KR101059275B1 (ko) * 2008-12-23 2011-08-24 일동제약주식회사 개선된 4-[2-(디-엔-프로필아미노)에틸]-1,3-디하이드로-2에이치-인돌-2-온의 제조 방법
WO2011072704A1 (en) * 2009-12-16 2011-06-23 Pharmathen S.A. Process for the preparation of ropinirole and salts thereof
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
CN102654045B (zh) * 2012-05-10 2015-07-08 中国石油天然气股份有限公司 顶部注空气重力辅助驱采油一维物理模拟实验系统
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754938A (en) 1980-09-20 1982-04-01 Konishiroku Photo Ind Co Ltd Developing method for positive type photosensitive lithographic printing plate
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法

Also Published As

Publication number Publication date
EP1848691A1 (en) 2007-10-31
JP2008530201A (ja) 2008-08-07
KR20070112196A (ko) 2007-11-22
US20080262244A1 (en) 2008-10-23
EP1848691B1 (en) 2009-11-11
ATE448201T1 (de) 2009-11-15
AU2006248578A1 (en) 2006-11-23
WO2006123356B1 (en) 2007-01-18
CA2597791A1 (en) 2006-11-23
BRPI0608244A2 (pt) 2016-02-10
WO2006123356A1 (en) 2006-11-23
ZA200707888B (en) 2009-01-28
ES2336486T3 (es) 2010-04-13
US7619095B2 (en) 2009-11-17
DE602006010329D1 (de) 2009-12-24

Similar Documents

Publication Publication Date Title
MX2010004688A (es) Usos terapeuticos de compuestos que tienen actividad combinada de sert, 5- ht3 y 5-ht1a.
ES2398434T8 (es) Isómeros ópticos de un metabolito de iloperidona
EA201000486A1 (ru) Ингибитор белка, активирующего 5-липоксигеназу (flap)
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
AR091771A2 (es) Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b]oxazol
NO20062370L (no) Amidderivater
NZ543722A (en) Novel substituted 3-sulfur indoles
NO20051527L (no) 3-(sulfonamidoetyl) -indol-derivater for anvendelse som glukocorticoid-mimetica ved behandling av inflammatoriske, allergiske og proliferative sykdommer.
DE60218703D1 (de) (-)-1-(3,4-dichlorphenyl)-3-azabicyclo ä3.1.0ühexan, zusammensetzungen davon und verwendung als dopamin-wiederaufnahme-hemmer
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
NZ594332A (en) Compounds for the prevention and treatment of cardiovascular disease
CN1370080A (zh) 用于治疗或抑制结肠息肉和结肠直肠癌的含有nsaid和efgr激酶抑制剂的组合物
TW200635904A (en) Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
MA38078A1 (fr) Dérivé de pyridine
CA2252898A1 (en) Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one(=ziprasidone), its preparation and its use as dopamine d2 antagonist
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
ZA200707888B (en) Process for the preparation of indolone derivative
AR049699A1 (es) Derivados de pirimidina
AR056103A1 (es) Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1
EA202092146A1 (ru) Производные пиразотетрагидроизохинолина в качестве положительных модуляторов допаминового d1 рецептора
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
JP2005521705A5 (pl)
WO2010092591A3 (en) Crystalline polymorphs of 5-[[(2r,3s)-2-[(1r)-1-[3,5- bis(trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2- dihydro-3h-1,2,4-triazol-3-one and process for preparation thereof
PE20060632A1 (es) Derivados de arilsulfonilestilbeno como antagonistas de los receptores 5-ht2a
PE20070355A1 (es) Antagonistas de cgrp seleccionados y procedimientos para su preparacion